Abera Bioscience Investor Relations Material
Latest events
Q1 2025
13 May, 2025
Q4 2024
13 Feb, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Abera Bioscience
Access all reports
Abera Bioscience AB is a Sweden-based biotechnology company specializing in vaccine development. The company focuses on creating next-generation vaccines using its proprietary platform technology, which is designed to enhance immune response and target a wide range of diseases. The company is headquartered in Solna, Sweden, and its shares are listed on the Spotlight Stock Market.
Latest articles
)
Nintendo: From Game Boy and Pokémon to Switch 2 and Mario Kart
Nintendo went from card maker to cultural icon, shaping modern entertainment through hardware innovation and world-famous characters.
19 Jun 2025
)
Ron Vachris: From Forklift Driver to CEO at Costco
Ron Vachris took over as Costco CEO in 2024, following a 40-year journey from warehouse floors to the top of one of retail's most admired companies.
18 Jun 2025
)
Luca de Meo: Succeeding Pinault as the New CEO of Kering
Luca de Meo's leap from auto to luxury marks a bold new chapter as he becomes the first non-Pinault CEO to lead the Kering empire.
16 Jun 2025
Ticker symbol
ABERA
Country
🇸🇪 Sweden